Real-World Evidence (RWE): The need for a multi-stakeholder approach

EUCOPE's Sounds of Science

EUCOPE

Science, Life Sciences

0 • 0 Ratings

🗓️ 18 August 2023

⏱️ 51 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

SOUNDS OF SCIENCE - EPISODE 17

On this episode, we explore the topic of Real-World Data and Real-World Evidence – that is data that is collected in a real-world setting, such as in healthcare institutions rather than through controlled experiments. We examine how and why this information can be useful for biopharma companies and health authorities, in order to bring new innovative therapies to patients. We will also look into some of the challenges with using this type of data, and view how a multi-stakeholder initiative - RWE4Decisions - is tackling those issues. Our special guests include:

Karen Facey, Senior Advisor HTA, RWE4Decisions
Carlos Martin Saborido, Scientific Officer, Spanish Ministry of Health
Alexander Natz, Secretary General, EUCOPE

===================================================================================================================

For more information on EUCOPE’s initiatives with Real-World Evidence or how your organisation can contribute to it, please contact Matias Olsen [email protected]

If your company would like to put forward a topic for us to discuss or to participate in a future podcast episode, please reach out to our producer, Dante Di Iulio.

Transcript

Click on a timestamp to play from that location

0:00.0	Hello everybody and welcome back to Sounds of Science, a series of podcasts hosted by
0:08.0	Yukope, the European Trade Body representing small and mid-sized companies active in health technologies.
0:14.0	My name is Dante and I'll be your host on today's pod. Before moving forward, I kindly ask you to hit the subscribe button
0:20.0	and also follow us on Twitter and LinkedIn to stay up to date on all of the latest news and initiatives within the world of European life sciences.
0:29.7	On today's episode, we will explore the topic of real world data and real world evidence.
0:34.4	That is data that is collected in the real-world setting, such
0:37.9	as in healthcare institutions, rather than through controlled experiments. We'll examine how
0:42.6	this information can be useful for biofarmac companies and health authorities in order to bring
0:47.4	new innovative therapies to patients. We will also look at some of the challenges with using
0:52.3	this type of data. We will see how a multi-stakeholder initiative, RWE4 Decisions, is tackling those issues.
0:59.0	With us today we welcome.
1:00.0	Karen Facey, Senior Advisor, HDA for RW for Decisions and FIPPR as well.
1:07.0	Welcome, Karen.
1:09.0	Nice to be with you, thank you.
1:11.6	We have Carlos Martin Saburido,
1:13.6	scientific officer for the Spanish Ministry of Health.
1:16.6	Welcome, Carlos.
1:18.6	Thank you. Nice to be here.
1:20.6	And of course, our perennial guest,
1:22.6	Alexander Nat, Secretary General of Yukope.
1:24.6	Welcome again, Alex.
1:26.6	Thanks, Danters. Thanks for having me again.
	...

Please login to see the full transcript.

Previous episode

Disclaimer: The podcast and artwork embedded on this page are from EUCOPE, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of EUCOPE and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.